Vincent M DeStefano - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Stem Cell Reviews and Reports|June 23, 2025

Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-UpMin Wang, Vincent M DeStefano, Ling Ding, et al.

Journal of Hematology & Oncology|January 30, 2026

BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trialMing Hong, Mingxia Wang, Ronghao Zeng, et al.

Annals of the Rheumatic Diseases|May 22, 2024

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trialWeijia Wang, Shanzhi He, Wenli Zhang, et al.

Frontiers in Immunology|August 18, 2025

Case report of non-gene editing CD7 CAR T cell therapy in CD7+ Sézary syndrome: preclinical validation and first-in-human useHaichan Xu, Lihua Sun, Zehua Wu, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Stem Cell Reviews and Reports|June 23, 2025

Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-UpMin Wang, Vincent M DeStefano, Ling Ding, et al.

Journal of Hematology & Oncology|January 30, 2026

BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trialMing Hong, Mingxia Wang, Ronghao Zeng, et al.

Annals of the Rheumatic Diseases|May 22, 2024

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trialWeijia Wang, Shanzhi He, Wenli Zhang, et al.

Frontiers in Immunology|August 18, 2025

Case report of non-gene editing CD7 CAR T cell therapy in CD7+ Sézary syndrome: preclinical validation and first-in-human useHaichan Xu, Lihua Sun, Zehua Wu, et al.

Pageof 1